Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: The ERIC study.
Journal
Alimentary pharmacology & therapeutics
ISSN: 1365-2036
Titre abrégé: Aliment Pharmacol Ther
Pays: England
ID NLM: 8707234
Informations de publication
Date de publication:
05 Sep 2024
05 Sep 2024
Historique:
revised:
13
03
2024
received:
29
01
2024
accepted:
27
08
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
5
9
2024
Statut:
aheadofprint
Résumé
Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment. To evaluate the long-term outcomes of patients who underwent early ileal resection. We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging). Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4-35.2]), than the intermediate (16.8% [95% CI 10.5-26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1-33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02). Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.
Sections du résumé
BACKGROUND
BACKGROUND
Early complicated Crohn's disease (CD) may require ileal resection as first-line treatment.
AIM
OBJECTIVE
To evaluate the long-term outcomes of patients who underwent early ileal resection.
METHODS
METHODS
We conducted a retrospective study in two inflammatory bowel diseases (IBD) referral centres, including patients with ileocaecal resection and segmental ileal resection within 5 years of CD diagnosis. Early resection was defined as within 6 months of diagnosis, intermediate resection between 6 months and 2 years, and late resection between 2 and 5 years. The primary outcome was the cumulative risk of a second ileal surgery. Secondary outcomes included the use of postoperative treatments and morphological recurrence after initial surgery (Rutgeerts score ≥i2, or recurrence on imaging).
RESULTS
RESULTS
Among 393 patients who underwent ileal resection within 5 years of diagnosis, 130, 128 and 135, respectively, had early, intermediate and late resection. The cumulative risk of second surgery at 10 years was not significantly different in the early resection group (25.0% [95% CI 17.4-35.2]), than the intermediate (16.8% [95% CI 10.5-26.2]; p = 0.17) or late resection group (22.7% [95% CI 15.1-33.3]; p = 0.83). The early resection group required fewer postoperative treatments than the late resection group with median survivals without treatments of 3.7 and 0.9 years, respectively (p = 0.002). Patients who had early resection had significantly less morphological recurrence than the late resection group (p = 0.02).
CONCLUSION
CONCLUSIONS
Early ileal resection in CD is not associated with a higher risk of a second resection. It may be associated with reduced use of medical treatments and fewer morphological recurrences.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
Références
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population‐based studies. Lancet. 2017;390:2769–2778.
Torres J, Mehandru S, Colombel J‐F, Peyrin‐Biroulet L. Crohn's disease. Lancet. 2017;389:1741–1755.
Burisch J, Kiudelis G, Kupcinskas L, Kievit HAL, Andersen KW, Andersen V, et al. Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population‐based inception cohort: an Epi‐IBD study. Gut. 2019;68:423–433.
Cosnes J, Gower‐Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.
Spinelli A, Carvello M, Adamina M, Panis Y, Warusavitarne J, Tulchinsky H, et al. Patients' perceptions of surgery for inflammatory bowel disease. Color Dis. 2021;23:2690–2698.
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, et al. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open‐label, multicentre trial. Lancet Gastroenterol Hepatol. 2017;2:785–792.
Stevens TW, Haasnoot ML, D'Haens GR, Buskens CJ, de Groof EJ, Eshuis EJ, et al. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long‐term follow‐up of the LIR!C trial. Lancet Gastroenterol Hepatol. 2020;5:900–907.
de Groof EJ, Stevens TW, Eshuis EJ, Gardenbroek TJ, Bosmans JE, van Dongen J, et al. Cost‐effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C trial. Gut. 2019;68:1774–1780.
Agrawal M, Ebert AC, Poulsen G, Ungaro RC, Faye AS, Jess T, et al. Early ileocecal resection for Crohn's disease is associated with improved long‐term outcomes compared to anti‐tumor necrosis factor therapy: a population‐based cohort study. Gastroenterology. 2023;165(4):976–985.
Kelm M, Anger F, Eichlinger R, Brand M, Kim M, Reibetanz J, et al. Early ileocecal resection is an effective therapy in isolated Crohn's disease. J Clin Med. 2021;10:731.
Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R. Early versus late surgery for ileo‐caecal Crohn's disease. Aliment Pharmacol Ther. 2007;26:1303–1312.
Sarikaya MZ, Zhao M, Lo B, Bendtsen F, Burisch J. Disease course and treatment outcomes of Crohn's disease patients with early or late surgery—a Danish nationwide cohort study from 1997 to 2015. Dig Liver Dis. 2023;55:872–879.
Peyrin‐Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV Jr. Surgery in a population‐based cohort of Crohn's disease from Olmsted County, Minnesota (1970‐2004). Am J Gastroenterol. 2012;107:1693–1701.
Le Baut G, Kirchgesner J, Amiot A, Lefevre JH, Chafai N, Landman C, et al. A scoring system to determine Patients' risk of colectomy within 1 year after hospital admission for acute severe ulcerative colitis. Clin Gastroenterol Hepatol. 2021;19:1602–1610.e1.
Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 1990;99:956–963.
Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, et al. The second European evidence‐based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis. 2010;4:63–101.
Maaser C, Sturm A, Vavricka SR, et al. ECCO‐ESGAR Guideline for Diagnostic Assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohn's Colitis. 2019;13:144–164K.
Sailer J, Peloschek P, Reinisch W, Vogelsang H, Turetschek K, Schima W. Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol. 2008;18:2512–2521.
Schaefer M, Laurent V, Grandmougin A, Vuitton L, Bourreille A, Luc A, et al. A magnetic resonance imaging index to predict Crohn's disease postoperative recurrence: the MONITOR index. Clin Gastroenterol Hepatol. 2022;20:e1040–e1049.
Beelen EMJ, Arkenbosch JHC, Erler NS, Sleutjes JAM, Hoentjen F, Bodelier AGL, et al. Impact of timing of primary ileocecal resection on prognosis in patients with Crohn's disease. BJS Open. 2023;7:zrad097.
Aaltonen G, Keränen I, Carpelan‐Holmström M, Lepistö A. Risk factors for anastomotic recurrence after primary ileocaecal resection in Crohn's disease. Eur J Gastroenterol Hepatol. 2018;30:1143–1147.
Aaltonen G, Carpelan‐Holmström M, Keränen I, Lepistö A. Surgical recurrence in Crohn's disease: a comparison between different types of bowel resections. Int J Color Dis. 2018;33:473–477.